Protodeltonin TN2106
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Protodeltonin may have anti-thrombotic activity by both improving the anticoagulation activity and inhibiting platelet aggregation action. Protodeltonin can inhibit the proliferation of a panel of established human and murine cancer cell lines in vitro.
CAS nr:
94992-08-2
Purity:
98%
Molecular Weight:
1065,21
SMILES:
C[C@H]1[C@H]2[C@H](C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)C)C)O[C@@]1(CC[C@@H](C)CO[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O
Formula:
C51H84O23
Pathway:
Proteases/Proteasome,Apoptosis,DNA Damage/DNA Repair,Chromatin/Epigenetic,Apoptosis
Target:
Caspase,Caspase,PARP,PARP,BCL
